Squarepoint Ops LLC Grifols Sa Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.37 - $12.73 $1.47 Million - $1.8 Million	-141,347 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $1.44 Million - $2.16 Million	141,347 New	141,347 $1.59 Million
Q4 2020 Feb 16, 2021	SELL	$16.86 - $19.67 $593,320 - $692,206	-35,191 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$15.4 - $20.16 $31,847 - $41,690	2,068 Added 6.24%	35,191 $611,000
Q2 2020 Aug 14, 2020	BUY	$18.24 - $21.45 $604,163 - $710,488	33,123 New	33,123 $604,000
Q4 2019 Feb 14, 2020	SELL	$19.57 - $23.52 $1.46 Million - $1.75 Million	-74,495 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $1.11 Million - $1.27 Million	55,895 Added 300.51%	74,495 $1.49 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $327,174 - $392,460	18,600 New	18,600 $392,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.